AMPH
Amphastar Pharmaceuticals Inc
Price:  
43.35 
USD
Volume:  
247,766.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AMPH EV/EBITDA

-0.7%
Upside

As of 2024-05-24, the EV/EBITDA ratio of Amphastar Pharmaceuticals Inc (AMPH) is 9.06. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AMPH's latest enterprise value is 2,511.80 mil USD. AMPH's TTM EBITDA according to its financial statements is 277.14 mil USD. Dividing these 2 quantities gives us the above AMPH EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 6.4x - 9.3x 8.3x
Forward P/E multiples 10.2x - 11.1x 10.5x
Fair Price 28.13 - 50.10 43.04
Upside -35.1% - 15.6% -0.7%
43.35 USD
Stock Price
43.04 USD
Fair Price

AMPH EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-23 9.06
2024-05-22 9.08
2024-05-21 8.81
2024-05-20 9.01
2024-05-17 9.09
2024-05-16 8.96
2024-05-15 8.90
2024-05-14 8.70
2024-05-13 8.89
2024-05-10 8.86
2024-05-09 8.90
2024-05-08 8.86
2024-05-07 8.96
2024-05-06 8.95
2024-05-03 8.91
2024-05-02 8.94
2024-05-01 8.84
2024-04-30 8.69
2024-04-29 8.83
2024-04-26 8.67
2024-04-25 8.62
2024-04-24 8.65
2024-04-23 8.63
2024-04-22 8.50
2024-04-19 8.47
2024-04-18 8.23
2024-04-17 8.48
2024-04-16 8.63
2024-04-15 8.61
2024-04-12 8.41
2024-04-11 8.50
2024-04-10 8.48
2024-04-09 8.63
2024-04-08 8.66
2024-04-05 8.79
2024-04-04 8.74
2024-04-03 8.81
2024-04-02 8.88
2024-04-01 9.08
2024-03-28 9.16
2024-03-27 9.09
2024-03-26 9.04
2024-03-25 9.11
2024-03-22 9.12
2024-03-21 9.27
2024-03-20 9.18
2024-03-19 9.28
2024-03-18 8.97
2024-03-15 9.01
2024-03-14 9.03